Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of Pacira Pharmaceuticals patents

Patents where

Current Assignee

Name

‌

Pacira Pharmaceuticals

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 9205052 Sustained-release liposomal anesthetic compositions	Patent 9205052 was granted and assigned to Pacira Pharmaceuticals on December, 2015 by the United States Patent and Trademark Office.	‌ Pacira Pharmaceuticals	‌ Pacira Pharmaceuticals	United States Patent and Trademark Office	9205052	December 8, 2015
‌ US Patent 10398648 Method for formulating large diameter synthetic membrane vesicles	Patent 10398648 was granted and assigned to Pacira Pharmaceuticals on September, 2019 by the United States Patent and Trademark Office.	‌ Pacira Pharmaceuticals	‌ Pacira Pharmaceuticals	United States Patent and Trademark Office	10398648	September 3, 2019
‌ US Patent 11759459 Treatment of pain by subarachnoid administration of sustained-release liposomal anesthetic compositions	Patent 11759459 was granted and assigned to Pacira Pharmaceuticals on September, 2023 by the United States Patent and Trademark Office.	‌ Pacira Pharmaceuticals	‌ Pacira Pharmaceuticals	United States Patent and Trademark Office	11759459	September 19, 2023
‌ US Patent 9192575 Sustained-release liposomal anesthetic compositions	Patent 9192575 was granted and assigned to Pacira Pharmaceuticals on November, 2015 by the United States Patent and Trademark Office.	‌ Pacira Pharmaceuticals	‌ Pacira Pharmaceuticals	United States Patent and Trademark Office	9192575	November 24, 2015
‌ US Patent 8182835 Sustained-release liposomal anesthetic compositions	Patent 8182835 was granted and assigned to Pacira Pharmaceuticals on May, 2012 by the United States Patent and Trademark Office.		‌ Pacira Pharmaceuticals	United States Patent and Trademark Office	8182835	May 22, 2012
‌ US Patent 9730892 Method for formulating large diameter synthetic membrane vesicles	Patent 9730892 was granted and assigned to Pacira Pharmaceuticals on August, 2017 by the United States Patent and Trademark Office.	‌ Pacira Pharmaceuticals	‌ Pacira Pharmaceuticals	United States Patent and Trademark Office	9730892	August 15, 2017
‌ US Patent 9585838 Production of multivesicular liposomes	Patent 9585838 was granted and assigned to Pacira Pharmaceuticals on March, 2017 by the United States Patent and Trademark Office.		‌ Pacira Pharmaceuticals	United States Patent and Trademark Office	9585838	March 7, 2017
‌ US Patent 11278494 Manufacturing of bupivacaine multivesicular liposomes	Patent 11278494 was granted and assigned to Pacira Pharmaceuticals on March, 2022 by the United States Patent and Trademark Office.	‌ Pacira Pharmaceuticals	‌ Pacira Pharmaceuticals	United States Patent and Trademark Office	11278494	March 22, 2022
‌ US Patent 11179336 Manufacturing of bupivacaine multivesicular liposomes	Patent 11179336 was granted and assigned to Pacira Pharmaceuticals on November, 2021 by the United States Patent and Trademark Office.	‌ Pacira Pharmaceuticals	‌ Pacira Pharmaceuticals	United States Patent and Trademark Office	11179336	November 23, 2021
‌ US Patent 11304904 Manufacturing of bupivacaine multivesicular liposomes	Patent 11304904 was granted and assigned to Pacira Pharmaceuticals on April, 2022 by the United States Patent and Trademark Office.	‌ Pacira Pharmaceuticals	‌ Pacira Pharmaceuticals	United States Patent and Trademark Office	11304904	April 19, 2022
‌ US Patent 11311486 Manufacturing of bupivacaine multivesicular liposomes	Patent 11311486 was granted and assigned to Pacira Pharmaceuticals on April, 2022 by the United States Patent and Trademark Office.	‌ Pacira Pharmaceuticals	‌ Pacira Pharmaceuticals	United States Patent and Trademark Office	11311486	April 26, 2022
‌ US Patent 11357727 Manufacturing of bupivacaine multivesicular liposomes	Patent 11357727 was granted and assigned to Pacira Pharmaceuticals on June, 2022 by the United States Patent and Trademark Office.	‌ Pacira Pharmaceuticals	‌ Pacira Pharmaceuticals	United States Patent and Trademark Office	11357727	June 14, 2022
‌ US Patent 11185506 Manufacturing of bupivacaine multivesicular liposomes	Patent 11185506 was granted and assigned to Pacira Pharmaceuticals on November, 2021 by the United States Patent and Trademark Office.	‌ Pacira Pharmaceuticals	‌ Pacira Pharmaceuticals	United States Patent and Trademark Office	11185506	November 30, 2021
‌ US Patent 11033495 Manufacturing of bupivacaine multivesicular liposomes	Patent 11033495 was granted and assigned to Pacira Pharmaceuticals on June, 2021 by the United States Patent and Trademark Office.	‌ Pacira Pharmaceuticals	‌ Pacira Pharmaceuticals	United States Patent and Trademark Office	11033495	June 15, 2021
‌ US Patent 9770414 Sustained release formulation of methotrexate as a disease-modifying antirheumatic drug (DMARD) and an anti-cancer agent	Patent 9770414 was granted and assigned to Pacira Pharmaceuticals on September, 2017 by the United States Patent and Trademark Office.		‌ Pacira Pharmaceuticals	United States Patent and Trademark Office	9770414	September 26, 2017
‌ US Patent 11426348 Compositions of bupivacaine multivesicular liposomes	Patent 11426348 was granted and assigned to Pacira Pharmaceuticals on August, 2022 by the United States Patent and Trademark Office.	‌ Pacira Pharmaceuticals	‌ Pacira Pharmaceuticals	United States Patent and Trademark Office	11426348	August 30, 2022
‌ US Patent 8834921 Sustained-release liposomal anesthetic compositions	Patent 8834921 was granted and assigned to Pacira Pharmaceuticals on September, 2014 by the United States Patent and Trademark Office.		‌ Pacira Pharmaceuticals	United States Patent and Trademark Office	8834921	September 16, 2014
‌ US Patent 11040011 Zinc meloxicam complex microparticle multivesicular liposome formulations and processes for making the same	Patent 11040011 was granted and assigned to Pacira Pharmaceuticals on June, 2021 by the United States Patent and Trademark Office.	‌ Pacira Pharmaceuticals	‌ Pacira Pharmaceuticals	United States Patent and Trademark Office	11040011	June 22, 2021
‌ US Patent 9737482 Method for formulating large diameter synthetic membrane vesicles	Patent 9737482 was granted and assigned to Pacira Pharmaceuticals on August, 2017 by the United States Patent and Trademark Office.	‌ Pacira Pharmaceuticals	‌ Pacira Pharmaceuticals	United States Patent and Trademark Office	9737482	August 22, 2017
‌ US Patent 10028911 Sustained release formulation of methotrexate as a disease-modifying antirheumatic drug (DMARD) and an anti-cancer agent	Patent 10028911 was granted and assigned to Pacira Pharmaceuticals on July, 2018 by the United States Patent and Trademark Office.	‌ Pacira Pharmaceuticals	‌ Pacira Pharmaceuticals	United States Patent and Trademark Office	10028911	July 24, 2018
‌ US Patent 10123974 Sustained release formulation of a non-steroidal anti-inflammatory drug	Patent 10123974 was granted and assigned to Pacira Pharmaceuticals on November, 2018 by the United States Patent and Trademark Office.	‌ Pacira Pharmaceuticals	‌ Pacira Pharmaceuticals	United States Patent and Trademark Office	10123974	November 13, 2018
‌ US Patent 9808424 Method for formulating large diameter synthetic membrane vesicles	Patent 9808424 was granted and assigned to Pacira Pharmaceuticals on November, 2017 by the United States Patent and Trademark Office.	‌ Pacira Pharmaceuticals	‌ Pacira Pharmaceuticals	United States Patent and Trademark Office	9808424	November 7, 2017
‌ US Patent 9724302 Method for formulating large diameter synthetic membrane vesicles	Patent 9724302 was granted and assigned to Pacira Pharmaceuticals on August, 2017 by the United States Patent and Trademark Office.	‌ Pacira Pharmaceuticals	‌ Pacira Pharmaceuticals	United States Patent and Trademark Office	9724302	August 8, 2017
‌ US Patent 10045941 Method for formulating large diameter synthetic membrane vesicles	Patent 10045941 was granted and assigned to Pacira Pharmaceuticals on August, 2018 by the United States Patent and Trademark Office.	‌ Pacira Pharmaceuticals	‌ Pacira Pharmaceuticals	United States Patent and Trademark Office	10045941	August 14, 2018
‌ US Patent 10709665 Zinc meloxicam complex microparticle multivesicular liposome formulations and processes for making the same	Patent 10709665 was granted and assigned to Pacira Pharmaceuticals on July, 2020 by the United States Patent and Trademark Office.	‌ Pacira Pharmaceuticals	‌ Pacira Pharmaceuticals	United States Patent and Trademark Office	10709665	July 14, 2020

Results per page:

36 results

0 selected

36 results

0 selected